Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121334023 | 12133402 | 3 | F | 20160121 | 20160922 | 20160301 | 20160928 | EXP | CA-AMGEN-CANSP2016022884 | AMGEN | 81.00 | YR | E | F | Y | 0.00000 | 20160928 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121334023 | 12133402 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 121334023 | 12133402 | 2 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | 200 MG, BID | 0 | 200 | MG | BID | |||||||
| 121334023 | 12133402 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 20 MG, QWK | 0 | 20 | MG | /wk | |||||||
| 121334023 | 12133402 | 4 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 500 MG, QD | 0 | 500 | MG | QD | |||||||
| 121334023 | 12133402 | 5 | C | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | UNK | 0 | |||||||||||
| 121334023 | 12133402 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | UNK | 0 | |||||||||||
| 121334023 | 12133402 | 7 | C | ROSUVASTATIN. | ROSUVASTATIN | 1 | UNK | 0 | |||||||||||
| 121334023 | 12133402 | 8 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 121334023 | 12133402 | 9 | C | PERINDOPRIL | PERINDOPRIL | 1 | UNK | 0 | |||||||||||
| 121334023 | 12133402 | 10 | C | CELEBREX | CELECOXIB | 1 | Oral | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121334023 | 12133402 | 1 | Rheumatoid arthritis |
| 121334023 | 12133402 | 2 | Product used for unknown indication |
| 121334023 | 12133402 | 3 | Rheumatoid arthritis |
| 121334023 | 12133402 | 4 | Rheumatoid arthritis |
| 121334023 | 12133402 | 10 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121334023 | 12133402 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121334023 | 12133402 | Bone erosion | |
| 121334023 | 12133402 | C-reactive protein abnormal | |
| 121334023 | 12133402 | Drug ineffective | |
| 121334023 | 12133402 | Foot deformity | |
| 121334023 | 12133402 | Grip strength decreased | |
| 121334023 | 12133402 | Hip arthroplasty | |
| 121334023 | 12133402 | Hypoaesthesia | |
| 121334023 | 12133402 | Joint swelling | |
| 121334023 | 12133402 | Knee arthroplasty | |
| 121334023 | 12133402 | Musculoskeletal disorder | |
| 121334023 | 12133402 | Pain in extremity | |
| 121334023 | 12133402 | Red blood cell sedimentation rate abnormal | |
| 121334023 | 12133402 | Treatment noncompliance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121334023 | 12133402 | 1 | 2011 | 2012 | 0 | |
| 121334023 | 12133402 | 3 | 2012 | 0 |